These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2199586)

  • 1. [The concept of and countermeasures in refractory anemia].
    Yoshida Y
    Nihon Naika Gakkai Zasshi; 1990 May; 79(5):593-7. PubMed ID: 2199586
    [No Abstract]   [Full Text] [Related]  

  • 2. Classification of the myelodysplastic syndromes.
    Bennett JM
    Clin Haematol; 1986 Nov; 15(4):909-23. PubMed ID: 3471370
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
    Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
    Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelodysplastic syndromes: natural history and features of prognostic importance.
    Mufti GJ; Galton DA
    Clin Haematol; 1986 Nov; 15(4):953-71. PubMed ID: 3552350
    [No Abstract]   [Full Text] [Related]  

  • 5. [The morphofunctional characteristics of the bone marrow erythroid cells in some forms of the myelodysplastic syndrome].
    Sarycheva TG; Tsvetaeva NV; Kozinets GI
    Ter Arkh; 1993; 65(7):52-4. PubMed ID: 8211781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing nonleukemic death in refractory anemia, refractory anemia with ring sideroblasts, and refractory anemia with excess of blasts.
    Oguma S; Yoshida Y; Uchino H; Maekawa T
    Cancer Res; 1987 Jul; 47(13):3599-602. PubMed ID: 3581090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of anemia in myelodysplastic syndromes with recombinant human erythropoietin].
    Rodríguez JN; Prados D; Martino ML; Muñiz R
    Sangre (Barc); 1993 Aug; 38(4):340-1. PubMed ID: 8235952
    [No Abstract]   [Full Text] [Related]  

  • 8. Refractory anemia in the elderly.
    Gardner FH
    Adv Intern Med; 1987; 32():155-75. PubMed ID: 3548248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory myelodysplastic anaemias with hypocellular bone marrow.
    Yoshida Y; Oguma S; Uchino H; Maekawa T
    J Clin Pathol; 1988 Jul; 41(7):763-7. PubMed ID: 3410972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis, course and outcome of myelodysplasias].
    Riauzova LIu; Soloveĭ DIa; Iavorkovskiĭ LI; Iavorkovskiĭ LL; Grinberg LIa
    Gematol Transfuziol; 1988 Aug; 33(8):19-23. PubMed ID: 3192050
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical, hematologic and developmental characteristics of myelodysplastic syndromes. Study of a group of patients with a long-term follow-up].
    Di Giovanni S; Giallonardo P; Costa MP; Carducci P
    Recenti Prog Med; 1987 Feb; 78(2):63-8. PubMed ID: 3473582
    [No Abstract]   [Full Text] [Related]  

  • 12. Refractory anemia with ringed sideroblasts (primary acquired sideroblastic anemia).
    Tomonaga M
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1419-27. PubMed ID: 2854694
    [No Abstract]   [Full Text] [Related]  

  • 13. Undetectable peripheral blood CFU-GM as a prognostic indicator in myelodysplastic syndrome.
    Tennant GB; Jacobs A
    Leuk Res; 1988; 12(11-12):961-2. PubMed ID: 3216676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percentages of bone marrow blasts and chromosomal changes in patients with refractory anemia help to determine prognoses.
    Iwabuchi A; Ohyashiki K; Ohyashiki JH; Kimura Y; Lin KY; Aizawa S; Nehashi Y; Miyazawa K; Yaguchi M; Toyama K
    Int J Hematol; 1994 Oct; 60(3):207-13. PubMed ID: 7858240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome.
    Knipp S; Strupp C; Gattermann N; Hildebrandt B; Schapira M; Giagounidis A; Aul C; Haas R; Germing U
    Leuk Res; 2008 Jan; 32(1):33-7. PubMed ID: 17412418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant erythropoietin for refractory anemia with ring sideroblasts.
    Musto P; Catalano L; Andriani A; Bodenizza C; Cascavilla N; Di Renzo N; Melillo L; Cicoira L; Carotenuto M; Rotoli B
    Haematologica; 1992; 77(2):185-6. PubMed ID: 1398306
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical features of long-term survivors of refractory myelodysplastic anemias. A Japanese cooperative study.
    Yoshida Y; Oguma S; Uchino H; Maekawa T; Nomura T
    Leuk Res; 1992 Aug; 16(8):775-9. PubMed ID: 1528065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful allogeneic bone marrow transplantation for childhood-onset refractory anemia with ringed sideroblasts.
    Kook H; Kim CJ; Yoon WS; Ryang DW; Hwang TJ
    J Korean Med Sci; 2000 Feb; 15(1):103-4. PubMed ID: 10719819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in refractory anemias.
    Oguma S; Yoshida Y; Uchino H; Maekawa T
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1412-8. PubMed ID: 3247816
    [No Abstract]   [Full Text] [Related]  

  • 20. [RAEB with ringed sideroblasts in a 3-month-old boy].
    Nagasawa H; Kondou T; Yasuda K; Yamazaki Y; Nishida T; Yamada H
    Rinsho Ketsueki; 1987 Jul; 28(7):1181-6. PubMed ID: 3694825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.